Organon in den Nachrichten
Gesundheitstherapien und -produkte
Tamtam hat 20 aktuelle Artikel über Organon gefunden.
- Organon Stock: A Merger-Arbitrage Hold With Limited Upside (NYSE:OGN)
- Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
- Henlius
- Sun Pharma completes $11.75bn financing syndication for Organon acquisition
- Organon & Co. Shareholders Clear Sun Pharma Merger Deal
- Organon commits more than $1.3 million towards enabling choices and resilient demographies with UNFPA
- Sun Pharma's Organon deal set to reshape biosimilars competitive landscape
- White & Case advises Sun Pharma on US$11.75 billion acquisition of Organon
- Sun Pharma to buy Organon for more than $11 billion
- Sun Pharma strikes biopharma's largest deal of '26 with $11.75B buyout of Organon
- Organon: Deep Value With No Clear Catalysts (NYSE:OGN)
- Organon & Co. (NYSE:OGN) Given Average Recommendation of "Reduce" by Analysts
- TetraScience and Organon Collaborate to Modernize Quality Control Data Management
- Laborie Expands Portfolio with Acquisition of JADA System from Organon
- Organon Details Nexplanon Sales Practice Issue
- Organon CEO exits, company goes on hunt for successor as internal probe turns up 'improper' Nexplanon sales tactics
- Organon divests Jada System, sends 100 employees to Laborie Medical Technologies in $465M deal
- Organon and Henlius see FDA approval of Poherdy for HER2-positive breast cancers
- Organon and UNFPA advance reproductive health services
- Henlius, Organon win US FDA approval of first Perjeta biosimilar
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Organon?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden